Tags

Type your tag names separated by a space and hit enter

Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study.
Haematologica. 2018 Nov; 103(11):1881-1888.H

Abstract

Diet is a modifiable risk factor for several neoplasms but evidence for chronic lymphocytic leukemia (CLL) is sparse. Previous studies examining the association between single-food items and CLL risk have yielded mixed results, while few studies have been conducted on overall diet, reporting inconclusive findings. This study aimed to evaluate the association between adherence to three dietary patterns and CLL in the multicase-control study (MCC-Spain) study. Anthropometric, sociodemographic, medical and dietary information was collected for 369 CLL cases and 1605 controls. Three validated dietary patterns, Western, Prudent and Mediterranean, were reconstructed in the MCC-Spain data. The association between adherence to each dietary pattern and CLL was assessed, overall and by Rai stage, using mixed logistic regression models adjusted for potential confounders. High adherence to a Western dietary pattern (i.e. high intake of high-fat dairy products, processed meat, refined grains, sweets, caloric drinks, and convenience food) was associated with CLL [ORQ4 vs. Q1=1.63 (95%CI 1.11; 2.39); P-trend=0.02; OR 1-SD increase=1.19 (95%CI: 1.03; 1.37)], independently of Rai stages. No differences in the association were observed according to sex, Body Mass Index, energy intake, tobacco, physical activity, working on a farm, or family history of hematologic malignancies. No associations were observed for Mediterranean and Prudent dietary patterns and CLL. This study provides the first evidence for an association between a Western dietary pattern and CLL, suggesting that a proportion of CLL cases could be prevented by modifying dietary habits. Further research, especially with a prospective design, is warranted to confirm these findings.

Authors+Show Affiliations

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Spain. Epidemiology Unit and Girona Cancer Registry, Catalan Institute of Oncology, Girona, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Cancer Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain. Faculty of Medicine, University of Alcalá, Alcalá de Henares, Madrid, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Unit of Molecular Epidemiology and Genetic in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme (IDIBELL), Catalan Institute of Oncology, L' Hospitalet De Llobregat, Spain.Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Spain. Epidemiology Unit and Girona Cancer Registry, Catalan Institute of Oncology, Girona, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. ISGlobal, Barcelona, Spain. Universitat Pompeu Fabra (UPF), Barcelona, Spain.Unit of Molecular Epidemiology and Genetic in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme (IDIBELL), Catalan Institute of Oncology, L' Hospitalet De Llobregat, Spain.Unit of Information and Interventions in Infections and Cancer (UNIC-I&I), Cancer Epidemiology Research Programme, (IDIBELL), Catalan Institute of Oncology, L' Hospitalet De Llobregat, Spain.Hematology, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.Hematology Laboratory, Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.Hematology Laboratory, Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.Hospital Clinic de Barcelona, University of Barcelona, CIBERONC, Barcelona Spain.Hospital Clinic de Barcelona, University of Barcelona, CIBERONC, Barcelona Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. University of Cantabria - Marqués de Valdecilla Research Institute (IDIVAL), Santander, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. University Institute of Oncology (IUOPA), University of Oviedo, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Department of Preventive Medicine and Public Health, University of Granada, Spain. Instituto de Investigación Biosanitaria de Granada, Hospitales Universitarios de Granada, Spain.Hematology Department, Hospital del Mar, Barcelona, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. ISGlobal, Barcelona, Spain. Universitat Pompeu Fabra (UPF), Barcelona, Spain. Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Epidemiology Section, Public Health Division, Department of Health of Madrid, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. ISGlobal, Barcelona, Spain. Universitat Pompeu Fabra (UPF), Barcelona, Spain. Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Unit of Molecular Epidemiology and Genetic in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme (IDIBELL), Catalan Institute of Oncology, L' Hospitalet De Llobregat, Spain. PATH, Reproductive Health, Seattle, WA, USA.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Cancer Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain dcasabonne@iconcologia.net. Unit of Molecular Epidemiology and Genetic in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme (IDIBELL), Catalan Institute of Oncology, L' Hospitalet De Llobregat, Spain.

Pub Type(s)

Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

29954942

Citation

Solans, Marta, et al. "Adherence to the Western, Prudent, and Mediterranean Dietary Patterns and Chronic Lymphocytic Leukemia in the MCC-Spain Study." Haematologica, vol. 103, no. 11, 2018, pp. 1881-1888.
Solans M, Castelló A, Benavente Y, et al. Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study. Haematologica. 2018;103(11):1881-1888.
Solans, M., Castelló, A., Benavente, Y., Marcos-Gragera, R., Amiano, P., Gracia-Lavedan, E., Costas, L., Robles, C., Gonzalez-Barca, E., de la Banda, E., Alonso, E., Aymerich, M., Campo, E., Dierssen-Sotos, T., Fernández-Tardón, G., Olmedo-Requena, R., Gimeno, E., Castaño-Vinyals, G., Aragonés, N., ... Casabonne, D. (2018). Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study. Haematologica, 103(11), 1881-1888. https://doi.org/10.3324/haematol.2018.192526
Solans M, et al. Adherence to the Western, Prudent, and Mediterranean Dietary Patterns and Chronic Lymphocytic Leukemia in the MCC-Spain Study. Haematologica. 2018;103(11):1881-1888. PubMed PMID: 29954942.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study. AU - Solans,Marta, AU - Castelló,Adela, AU - Benavente,Yolanda, AU - Marcos-Gragera,Rafael, AU - Amiano,Pilar, AU - Gracia-Lavedan,Esther, AU - Costas,Laura, AU - Robles,Claudia, AU - Gonzalez-Barca,Eva, AU - de la Banda,Esmeralda, AU - Alonso,Esther, AU - Aymerich,Marta, AU - Campo,Elias, AU - Dierssen-Sotos,Trinidad, AU - Fernández-Tardón,Guillermo, AU - Olmedo-Requena,Rocio, AU - Gimeno,Eva, AU - Castaño-Vinyals,Gemma, AU - Aragonés,Nuria, AU - Kogevinas,Manolis, AU - de Sanjose,Silvia, AU - Pollán,Marina, AU - Casabonne,Delphine, Y1 - 2018/06/28/ PY - 2018/03/06/received PY - 2018/06/25/accepted PY - 2018/6/30/pubmed PY - 2019/10/11/medline PY - 2018/6/30/entrez SP - 1881 EP - 1888 JF - Haematologica JO - Haematologica VL - 103 IS - 11 N2 - Diet is a modifiable risk factor for several neoplasms but evidence for chronic lymphocytic leukemia (CLL) is sparse. Previous studies examining the association between single-food items and CLL risk have yielded mixed results, while few studies have been conducted on overall diet, reporting inconclusive findings. This study aimed to evaluate the association between adherence to three dietary patterns and CLL in the multicase-control study (MCC-Spain) study. Anthropometric, sociodemographic, medical and dietary information was collected for 369 CLL cases and 1605 controls. Three validated dietary patterns, Western, Prudent and Mediterranean, were reconstructed in the MCC-Spain data. The association between adherence to each dietary pattern and CLL was assessed, overall and by Rai stage, using mixed logistic regression models adjusted for potential confounders. High adherence to a Western dietary pattern (i.e. high intake of high-fat dairy products, processed meat, refined grains, sweets, caloric drinks, and convenience food) was associated with CLL [ORQ4 vs. Q1=1.63 (95%CI 1.11; 2.39); P-trend=0.02; OR 1-SD increase=1.19 (95%CI: 1.03; 1.37)], independently of Rai stages. No differences in the association were observed according to sex, Body Mass Index, energy intake, tobacco, physical activity, working on a farm, or family history of hematologic malignancies. No associations were observed for Mediterranean and Prudent dietary patterns and CLL. This study provides the first evidence for an association between a Western dietary pattern and CLL, suggesting that a proportion of CLL cases could be prevented by modifying dietary habits. Further research, especially with a prospective design, is warranted to confirm these findings. SN - 1592-8721 UR - https://www.unboundmedicine.com/medline/citation/29954942/full_citation DB - PRIME DP - Unbound Medicine ER -